Dergiler / ENT Updates / 2022 / Cilt: 12 - Sayı: 1

Chest Image Staging and Prevalence of Current Smoking Among Hospitalized COVID-19 Patients in Turkey

Sayfa
44–50
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

It seems that an elevated radiological stage is a predictor of death.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Novel coronavirus disease is a new infectious agent of the respiratory tract characterized by severe acute respiratory syndrome.
📊
Temel Bulgular & Veri:Methods: We collected data from 213 patients who were hospitalized into COVID-19 isolation with positive PCR test results.
💡
Sonuç & Katkı:It seems that an elevated radiological stage is a predictor of death.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Novel coronavirus disease is a new infectious agent of the respiratory tract characterized by severe acute respiratory syndrome. For this disease, there are limited data with regard to the clinical characteristics of the patients and prognostic factors. Methods: We collected data from 213 patients who were hospitalized into COVID-19 isolation with positive PCR test results. We recorded various patient values, including blood test results. We also noted age, gender, additional diseases, duration of discharge, whether they live or die, whether they smoke, and their radiological staging. Results: In CT imaging with a staging of maximum 4 points and minimum 0 points, the mean value resulted in 1.95. The average radiological stage of the dead patients' group was reported as 2.56. There was a correlation between the radiological predictor and the outcome status (P = .002). The number of smokers was 14 (6.5%). Of the 26 patients who died, 3 were smokers and 23 were non-smokers. Conclusion: Fourteen patients in the study were smokers. While in COVID-19 isolation service, only a small rate of smoking was observed. That supports the theory that smoking has no negative impact on COVID-19 development. There was also a correlation between the radiological predictor and the outcome status. It seems that an elevated radiological stage is a predictor of death.

🔖

Bu Makaleye Atıf Yap

EROĞLU, S., AYDOĞDU, İ., YOLUÇ, Ş. N., ŞAHİN, E., EROĞLU, Y. (2022). Chest Image Staging and Prevalence of Current Smoking Among Hospitalized COVID-19 Patients in Turkey. ENT Updates, Cilt: 12 - Sayı: 1, 44–50. https://ajindex.com/articles/501374

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (13)

  1. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. Lancet. 2020
  2. 395(10225):689-697. [CrossRef] 2. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a singlecentered, retrospective, observational study. Lancet Respir Med. 2020
  3. 8(5):475-481. [CrossRef] 3. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020
  4. 395(10223):507-513. [CrossRef] 4. Chung M, Bernheim A, Mei X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. 2020
  5. 295(1):202-207. [CrossRef] 5. Khot WY, Nadkar MY. The 2019 novel coronavirus outbreak: a global threat. J Assoc Physicians India. 2020
  6. 68(3):67-71. 6. Eapen MS, Sharma P, Moodley YP, Hansbro PM, Sohal SS. Dysfunctional immunity and microbial adhesion molecules in smokinginduced pneumonia. Am J Respir Crit Care Med. 2019
  7. 199(2):250-251. [CrossRef] 7. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-nCov. medRxiv. 2020:2020.02.05.20020107. [CrossRef] 8. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target. Intensive Care Med. 2020
  8. 46(4):586-590. [CrossRef] 9. Kuba K, Imai Y, Rao S, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med. 2005
  9. 11(8):875-879. [CrossRef] 10. Li K, Fang Y, Li W, et al. CT image visual quantitative evaluation and clinical classification of coronavirus disease (COVID-19). Eur Radiol. 2020
  10. 30(8):4407-4416.[CrossRef] 11. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020
  11. 395(10223):497-506. [CrossRef] 12. Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020
  12. 181(2):271-280.e8. [CrossRef] 13. Jia HP, Look DC, Shi L, et al. ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol. 2005
  13. 79(23):14614- 14621. [CrossRef] 14. Glowacka I, Bertram S, Herzog P